Physician profile
Steven M Ware
NPI 1437126430
$1,043.63
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $317 · 2022: $12.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $286.37 | 2019-2020 | |
| Astellas Pharma US INC | $252.73 | 2019-2020 | |
| Janssen Biotech, INC. | $114.19 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $70.50 | 2019-2020 | |
| Abbvie INC. | $67.44 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $54.70 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.20 | 2019-2020 | |
| Metuchen Pharmaceuticals | $25.86 | 2019-2020 | |
| Medtronic USA, INC. | $17.19 | 2019 | |
| Coloplast Corp | $16.28 | 2020 | |
| 180 Medical, INC. | $15.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.86 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.69 | 2019 | |
| Boston Scientific Corporation | $14.58 | 2019 | |
| Blue Earth Diagnostics | $14.01 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $13.81 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.